MEDP - Medpace Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
860,969
860,969
704,589
436,152
421,582
Cost of Revenue
615,272
615,272
489,059
261,463
249,471
Gross Profit
245,697
245,697
215,530
174,689
172,111
Operating Expenses
Selling General and Administrative
95,245
95,245
75,681
63,357
61,507
Total Operating Expenses
118,434
118,434
114,482
109,831
119,621
Operating Income or Loss
127,263
127,263
101,048
64,858
52,490
Total Other Income/Expenses Net
-863
-863
1,060
-354
-11,149
Income Before Tax
124,832
124,832
93,951
56,945
21,957
Income Tax Expense
24,389
24,389
20,766
17,823
8,532
Income from Continuing Operations
100,443
100,443
73,185
39,122
13,425
Net Income
100,443
100,443
73,185
39,122
13,425
Net Income available to common shareholders
100,164
100,164
72,894
39,032
13,392
Basic EPS
-
-
2.05
1.00
0.38
Diluted EPS
-
-
1.97
0.98
0.37
Basic Average Shares
-
-
35,547
39,056
35,690
Diluted Average Shares
-
-
36,912
39,839
36,329
EBITDA
-
150,452
139,849
111,332
110,604